NewGenIvf Group Limited

NASDAQ: NIVF · Real-Time Price · USD
1.87
-0.05 (-2.60%)
At close: Aug 15, 2025, 3:00 PM

NewGenIvf Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
457.74K 54.1K 54.72K 28.76K
Short-Term Investments
n/a 11.88K n/a n/a
Long-Term Investments
204K 21.26M 70.69M n/a
Other Long-Term Assets
33.33K -19.67M -506.34K n/a
Receivables
2.36M 519.55K 2.32M 750.35K
Inventory
80.81K 126.26K 46.91K 41.27K
Other Current Assets
73.92K 373.68K -2.33M n/a
Total Current Assets
3.17M 2.46M 91.73K 820.39K
Property-Plant & Equipment
371.67K 446K 506.34K 592.38K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
609K 2.03M 70.69M 592.38K
Total Assets
3.58M 4.49M 70.79M 1.41M
Account Payables
1.3M 172.63K 104.65K 46.93K
Deferred Revenue
63.49K 7.94K 1.36M 812.16K
Short-Term Debt
582.45K 213.57K n/a 512.82K
Other Current Liabilities
554.38K -15.59K -2.51M n/a
Total Current Liabilities
2.72M 1.12M 50K 2.07M
Long-Term Debt
2.33M n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 2.17M n/a
Total Long-Term Liabilities
2.34M 118.98K 2.42M 261.82K
Total Liabilities
5.06M 1.24M 2.46M 2.33M
Total Debt
3.03M 332.55K 452.04K 925.97K
Common Stock
n/a 21.27M 67.34M 5.6K
Retained Earnings
-985.99K -461.35K -591.54K -1.05M
Comprehensive Income
18.88K -7.29K 9.57K 10.85K
Shareholders Equity
-1.05M 3.74M 68.32M -775.94K
Total Investments
204K 21.27M 70.69M n/a